Healthcare provider profile · identity verified

Amanda Ford, DO

Family Practice · CONNELLY SPRINGS, NC · NPI 1245657105

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	317	76
Atorvastatin Calcium	Atorvastatin Calcium	301	87
Lisinopril	Lisinopril	280	77
Amlodipine Besylate	Amlodipine Besylate	241	68
Pantoprazole Sodium	Pantoprazole Sodium	235	61
Gabapentin	Gabapentin	216	61
Omeprazole	Omeprazole	205	61
Losartan Potassium	Losartan Potassium	203	53
Furosemide	Furosemide	196	59
Metformin Hcl Er	Metformin Hcl	167	48
Hydrochlorothiazide	Hydrochlorothiazide	163	42
Alprazolam	Alprazolam	153	35
Trazodone Hcl	Trazodone Hcl	145	44
Simvastatin	Simvastatin	141	40
Tramadol Hcl	Tramadol Hcl	138	48
Lorazepam	Lorazepam	137	36
Celecoxib	Celecoxib	130	46
Sertraline Hcl	Sertraline Hcl	126	33
Montelukast Sodium	Montelukast Sodium	122	32
Metoprolol Succinate	Metoprolol Succinate	120	35
Albuterol Sulfate Hfa	Albuterol Sulfate	111	42
Allopurinol	Allopurinol	105	25
Rosuvastatin Calcium	Rosuvastatin Calcium	102	30
Metformin Hcl	Metformin Hcl	99	31
Potassium Chloride	Potassium Chloride	98	23
Fluticasone Propionate	Fluticasone Propionate	93	33
Tamsulosin Hcl	Tamsulosin Hcl	91	27
Zolpidem Tartrate	Zolpidem Tartrate	91	20
Citalopram Hbr	Citalopram Hydrobromide	88	22
Famotidine	Famotidine	87	21
Meloxicam	Meloxicam	86	31
Clonazepam	Clonazepam	80	20
Eliquis	Apixaban	73	19
Duloxetine Hcl	Duloxetine Hcl	72	23
Carvedilol	Carvedilol	70	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	12
Clopidogrel	Clopidogrel Bisulfate	67	17
Metoprolol Tartrate	Metoprolol Tartrate	66	20
Glipizide	Glipizide	64	19
Ozempic	Semaglutide	63	15
Bupropion Xl	Bupropion Hcl	62	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	21
Escitalopram Oxalate	Escitalopram Oxalate	62	20
Prednisone	Prednisone	58	38
Fluoxetine Hcl	Fluoxetine Hcl	54	14
Amitriptyline Hcl	Amitriptyline Hcl	50	15
Cephalexin	Cephalexin	49	39
Tizanidine Hcl	Tizanidine Hcl	49	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	14
Topiramate	Topiramate	48	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	46	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	14
Triamcinolone Acetonide	Triamcinolone Acetonide	45	25
Fluconazole	Fluconazole	44	31
Ropinirole Hcl	Ropinirole Hcl	44	13
Baclofen	Baclofen	43	19
Buspirone Hcl	Buspirone Hcl	43	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	42	suppressed
Donepezil Hcl	Donepezil Hcl	41	12
Pravastatin Sodium	Pravastatin Sodium	41	12
Diclofenac Sodium	Diclofenac Sodium	40	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	14
Ondansetron Odt	Ondansetron	40	22
Atenolol	Atenolol	39	11
Cefdinir	Cefdinir	36	32
Ketoconazole	Ketoconazole	36	14
Pregabalin	Pregabalin	36	11
Finasteride	Finasteride	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Azithromycin	Azithromycin	34	32
Farxiga	Dapagliflozin Propanediol	34	14
Warfarin Sodium	Warfarin Sodium	34	suppressed
Amoxicillin	Amoxicillin	33	31
Ezetimibe	Ezetimibe	33	suppressed
Alendronate Sodium	Alendronate Sodium	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	13
Meclizine Hcl	Meclizine Hcl	31	14
Spironolactone	Spironolactone	31	suppressed
Methocarbamol	Methocarbamol	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Nabumetone	Nabumetone	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	11
Ibuprofen	Ibuprofen	28	15
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Testosterone	Testosterone	28	suppressed
Diazepam	Diazepam	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	27	13
Linzess	Linaclotide	27	13
Methylprednisolone	Methylprednisolone	27	24
Myrbetriq	Mirabegron	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	25
Chlorthalidone	Chlorthalidone	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Valsartan	Valsartan	23	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Jardiance	Empagliflozin	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Levofloxacin	Levofloxacin	20	11
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Nystatin	Nystatin	17	12
Temazepam	Temazepam	17	suppressed
Ursodiol	Ursodiol	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	12
Lamotrigine	Lamotrigine	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Betamethasone Valerate	Betamethasone Valerate	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Mounjaro	Tirzepatide	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Doxycycline Monohydrate	Doxycycline Monohydrate	13	12
Enalapril Maleate	Enalapril Maleate	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Cilostazol	Cilostazol	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error